CV Sciences reported a challenging third quarter for 2025, marked by a 16% decline in revenue year-over-year to $3.3 million. Despite a slight improvement in gross margin, the company posted a net ...
In the latest earnings call, CV Sciences (OTC: CVSI) announced a Q3 2024 revenue of $3.9 million, on par with previous quarters but slightly down from the same quarter last year.
Greetings, and welcome to the CV Sciences Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your ...
Greetings. Welcome to CV Sciences' First Quarter 2024 Conference Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation.
Operator: Greetings, and welcome to CV Sciences’ First Quarter 2025 Earnings Conference Call. At this time, participants are in a listen only mode. A question and answer session will follow the formal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results